| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6TNS415Y3P |
| InChI Key | UFPFGVNKHCLJJO-SSKFGXFMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H33FN4O3S |
| Molecular Weight | 500.64 |
| AlogP | 3.85 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 91.4 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 35.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
|
0 | 0-2720 | 10 | - | - | |
|
Other cytosolic protein
|
35-283 | 30-1050 | 53 | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Polycythemia Vera | 2 | D011087 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2431768 |
| DrugBank | DB12085 |
| FDA SRS | 6TNS415Y3P |
| Guide to Pharmacology | 7912 |
| PubChem | 24737642 |
| SureChEMBL | SCHEMBL1275369 |
| ZINC | ZINC000095929260 |